Additive effects of caspase inhibitor and lazaroid on the survival of transplanted rat and human embryonic dopamine neurons.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Experimental Neurology

• Publication date

  2000-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1006/EXNR.2000.7406PMID 10877920
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Dopaminergic neuronal survival and the effects of bFGF in explant, three dimensional and monolayer cultures of embryonic rat ventral mesencephalon

  2004cited by this paper
• Cyclosporin A increases survival of cross-species intrastriatal grafts of embryonic dopamine-containing neurons

  2004cited by this paper
• Behavioural effects of human fetal dopamine neurons grafted in a rat model of Parkinson's disease

  2004cited by this paper
• Temporal pattern of host responses against intrastriatal grafts of syngeneic, allogeneic or xenogeneic embryonic neuronal tissue in rats

  2004cited by this paper
• Improving the Survival of Grafted Dopaminergic Neurons: A Review over Current Approaches

  2000cited by this paper
• Bilateral caudate and putamen grafts of embryonic mesencephalic tissue treated with lazaroids in Parkinson's disease.

  2000cited by this paper
• Cerebral implantation in movement disorders: State of the art

  1999cited by this paper
• Non‐specific effects of methyl ketone peptide inhibitors of caspases

  1999cited by this paper
• The effect of microglia on embryonic dopaminergic neuronal survival in vitro: diffusible signals from neurons and glia change microglia from neurotoxic to neuroprotective

  1999cited by this paper
• Dopamine release from nigral transplants visualized in vivo in a Parkinson's patient

  1999cited by this paper
• Neuronal cell death: a demise with different shapes.

  1999cited by this paper
• Delayed implantation of nigral grafts improves survival of dopamine neurones and rate of functional recovery.

  1999cited by this paper
• Differential effects of Bcl‐2 overexpression on fibre outgrowth and survival of embryonic dopaminergic neurons in intracerebral transplants

  1999cited by this paper
• Activation of Fas by FasL induces apoptosis by a mechanism that cannot be blocked by Bcl-2 or Bcl-x(L).

  1999cited by this paper
• Caspase inhibition reduces apoptosis and increases survival of nigral transplants

  1999cited by this paper
• Sequential bilateral transplantation in Parkinson's disease: effects of the second graft.

  1999cited by this paper
• Effects of anaesthetics and lazaroid U-83836E on survival of transplanted rat dopaminergic neurones.

  1999cited by this paper
• Inhibition of Human Caspases by Peptide-based and Macromolecular Inhibitors*

  1998cited by this paper
• Quinolinic acid‐induced inflammation in the striatum does not impair the survival of neural allografts in the rat

  1998cited by this paper
• Fetal nigral grafts survive and mediate clinical benefit in a patient with Parkinson's disease

  1998cited by this paper
• Dual Signaling of the Fas Receptor: Initiation of Both Apoptotic and Necrotic Cell Death Pathways

  1998cited by this paper
• FETAL TISSUE TRANSPLANATION IN PARKINSON'S DISEASE

  1998cited by this paper
• Caspases: enemies within.

  1998cited by this paper
• Fetal tissue transplantation [correction of transplanation] in Parkinson's disease.

  1998cited by this paper
• Characterization of behavioral and neurodegenerative changes following partial lesions of the nigrostriatal dopamine system induced by intrastriatal 6-hydroxydopamine in the rat.

  1998cited by this paper
• Role of an acidic compartment in tumor-necrosis-factor-alpha-induced production of ceramide, activation of caspase-3 and apoptosis.

  1998cited by this paper
• Growth factors improve immediate survival of embryonic dopamine neurons after transplantation into rats.

  1998cited by this paper
• Neural transplantation: a hope for patients with Parkinson's disease

  1997cited by this paper
• Caspase-Mediated Apoptosis in Neuronal Excitotoxicity Triggered by Nitric Oxide

  1997cited by this paper
• Tirilazad mesylate increases dopaminergic neuronal survival in the in Oculo grafting model.

  1997cited by this paper
• Tirilazad mesylate improves survival of rat and human embryonic mesencephalic neurons in vitro.

  1997cited by this paper
• The lazaroid U-83836E improves the survival of rat embryonic mesencephalic tissue stored at 4 degrees C and subsequently used for cultures or intracerebral transplantation.

  1996cited by this paper
• Functional fetal nigral grafts in a patient with Parkinson's disease: Chemoanatomic, ultrastructural, and metabolic studies

  1996cited by this paper
• Fetal nigral transplantation as a therapy for Parkinson's disease.

  1996cited by this paper
• The time course of loss of dopaminergic neurons and the gliotic reaction surrounding grafts of embryonic mesencephalon to the striatum.

  1996cited by this paper
• Clinical correlates of {18F}fluorodopa uptake in five grafted Parkinsonian patients

  1995cited by this paper
• Overexpressing Cu/Zn superoxide dismutase enhances survival of transplanted neurons in a rat model of Parkinson's disease

  1995cited by this paper
• Ethical guidelines for the use of human embryonic or fetal tissue for experimental and clinical neurotransplantation and research

  1994cited by this paper
• Programmed cell death in developing grafts of fetal substantia nigra.

  1994cited by this paper
• Lazaroids improve the survival of grafted rat embryonic dopamine neurons.

  1994cited by this paper
• A microtransplantation approach for cell suspension grafting in the rat Parkinson model: a detailed account of the methodology.

  1994cited by this paper
• Human embryonic dopamine neurons xenografted to the rat: effects of cryopreservation and varying regional source of donor cells on transplant survival, morphology and function.

  1994cited by this paper
• Evaluation of the Pharmacokinetics and Tolerability of Tirilazad Mesylate, a 21‐Aminosteroid Free Radical Scavenger: I. Single‐Dose Administration

  1993cited by this paper
• Evaluation of the Pharmacokinetics and Tolerability of Tirilazad Mesylate, a 21‐Aminosteroid Free Radical Scavenger: II. Multiple‐Dose Administration

  1993cited by this paper
• Fetal tissue transplantation in Parkinson's disease.

  1993cited by this paper
• Novel inhibitors of iron‐dependent lipid peroxidation for neurodegenerative disorders

  1992cited by this paper
• Neural transplantation : a practical approach

  1992cited by this paper
• Correlation of functional recovery after a 6-hydroxydopamine lesion with survival of grafted fetal neurons and release of dopamine in the striatum of the rat.

  1991cited by this paper
• Unbiased stereological estimation of the total number of neurons in the subdivisions of the rat hippocampus using the optical fractionator

  1991cited by this paper
• The absolute number of nerve cells in substantia nigra in normal subjects and in patients with Parkinson's disease estimated with an unbiased stereological method.

  1991cited by this paper
• Effect of Prior Dopamine Denervation on Survival and Fiber Outgrowth from Intrastriatal Fetal Mesencephalic Grafts

  1990cited by this paper
• The 21-aminosteroid inhibitors of lipid peroxidation: reactions with lipid peroxyl and phenoxy radicals.

  1989cited by this paper
• The 21-aminosteroid inhibitors of lipid peroxidation: Reactions with lipid peroxyl and phenoxy radicals

  1989cited by this paper
• Survival and function of dissociated rat dopamine neurones grafted at different developmental stages or after being cultured in vitro.

  1988cited by this paper
• Monitoring of cell viability in suspensions of embryonic CNS tissue and its use as a criterion for intracerebral graft survival.

  1985cited by this paper
• The survival of brain transplants is enhanced by extracts from injured brain.

  1984cited by this paper
• The projections of the ventral tegmental area and adjacent regions: a combined fluorescent retrograde tracer and immunofluorescence study in the rat.

  1982cited by this paper
• Reinnervation of the denervated striatum by substantia nigra transplants: functional consequences as revealed by pharmacological and sensorimotor testing.

  1980cited by this paper
• Neuronal degeneration in rat brain induced by 6-hydroxydopamine; a histological and biochemical study.

  1972cited by this paper

• Stem Cell Therapy and Thiamine Deficiency-Induced Brain Damage

  2024cites this paper
• Preparation of Viable Human Neurites for Neurobiological and Neurodegeneration Studies

  2024cites this paper
• Incorporation of stem cell-derived astrocytes into neuronal organoids to allow neuro-glial interactions in toxicological studies.

  2020cites this paper
• Human neuronal signaling and communication assays to assess functional neurotoxicity

  2020cites this paper
• The neuroprotective action of lenalidomide on rotenone model of Parkinson's Disease: Neurotrophic and supportive actions in the substantia nigra pars compacta.

  2020cites this paper
• Chemical concentrations in cell culture compartments (C5) - concentration definitions.

  2019cites this paper
• Time and space-resolved quantification of plasma membrane sialylation for measurements of cell function and neurotoxicity

  2019cites this paper
• Template for the description of cell-based toxicological test methods to allow evaluation and regulatory use of the data_suppl

  2019cites this paper
• Major changes of cell function and toxicant sensitivity in cultured cells undergoing mild, quasi-natural genetic drift

  2018cites this paper
• Recommendation on test readiness criteria for new approach methods in toxicology: Exemplified for developmental neurotoxicity.

  2018cites this paper
• Design and validation of an ontology-driven animal-free testing strategy for developmental neurotoxicity testing.

  2018cites this paper
• New Animal-free Concepts and Test Methods for Developmental Toxicity and Peripheral Neurotoxicity

  2017cites this paper
• Adverse outcome pathways: opportunities, limitations and open questions

  2017cites this paper
• The effect of L-dopa and neuroprotective agents on cell replacement therapy for Parkinson's disease

  2017cites this paper
• Design of a high-throughput human neural crest cell migration assay to indicate potential developmental toxicants.

  2016cites this paper
• In vitro acute and developmental neurotoxicity screening: an overview of cellular platforms and high-throughput technical possibilities

  2016cites this paper
• Switching from astrocytic neuroprotection to neurodegeneration by cytokine stimulation

  2016cites this paper
• Both apoptosis and necrosis occur early after intracerebral grafting of ventral mesencephalic tissue : a role for protease activation

  2016influential citation
• Food for Thought …: Developmental Neurotoxicity – Challenges in the 21 st Century and In Vitro Opportunities

  2014cites this paper
• t 4 Workshop Report * State-ofthe-Art of 3 D Cultures ( Organs-ona-Chip ) in Safety Testing and Pathophysiology

  2014cites this paper
• Developmental neurotoxicity - challenges in the 21st century and in vitro opportunities.

  2014cites this paper
• State-of-the-art of 3D cultures (organs-on-a-chip) in safety testing and pathophysiology.

  2014cites this paper
• Two-step grafting significantly enhances the survival of foetal dopaminergic transplants and induces graft-derived vascularisation in a 6-OHDA model of Parkinson's disease.

  2014cites this paper
• Current approaches and future role of high content imaging in safety sciences and drug discovery.

  2014cites this paper
• Generation of genetically-modified human differentiated cells for toxicological tests and the study of neurodegenerative diseases.

  2013cites this paper
• Evaluation of a human neurite growth assay as specific screen for developmental neurotoxicants

  2013cites this paper
• The impact of oxidative stress in thiamine deficiency: a multifactorial targeting issue.

  2013cites this paper
• Degeneration mechanisms in human dopaminergic neurons

  2012cites this paper
• Effects of salvianolic acid B on survival, self-renewal and neuronal differentiation of bone marrow derived neural stem cells.

  2012cites this paper
• Novel technologies and an overall strategy to allow hazard assessment and risk prediction of chemicals, cosmetics, and drugs with animal-free methods.

  2012cites this paper
• Uncoupling of ATP-depletion and cell death in human dopaminergic neurons.

  2012cites this paper
• Compound selection for in vitro modeling of developmental neurotoxicity.

  2012cites this paper
• Stem Cells for Neurodegenerative Disorders

  2012cites this paper
• haracterization of embryonic cortical neuron death in prolonged cell suspension

  2012cites this paper
• BMSC and CoQ10 improve behavioural recovery and histological outcome in rat model of Parkinson's disease.

  2011cites this paper
• MEK/ERK pathway mediates cytoprotection of salvianolic acid B against oxidative stress‐induced apoptosis in rat bone marrow stem cells

  2010cites this paper
• A Calpain Inhibitor Enhances the Survival of Schwann Cells In Vitro and after Transplantation into the Injured Spinal Cord

  2010cites this paper
• Cell-based Therapeutic Approaches for Parkinson's Disease: Progress and Perspectives

  2009cites this paper
• Grafting of striatal precursor cells into hippocampus shortly after status epilepticus restrains chronic temporal lobe epilepsy.

  2008cites this paper
• Strategies for promoting anti-seizure effects of hippocampal fetal cells grafted into the hippocampus of rats exhibiting chronic temporal lobe epilepsy.

  2007cites this paper
• Neural stem cells for the treatment of disorders of the enteric nervous system: Strategies and challenges

  2007cites this paper
• 28 – Human Embryonic Stem Cells, Dopaminergic Neurons, and Pathways for Developing a Parkinson's Disease Therapy

  2007cites this paper
• Pleiotrophin promotes functional recovery after neural transplantation in rats

  2007cites this paper
• Stem Cells in Neurodegeneration and Injury

  2006cites this paper
• Transplantation in Parkinson's disease: The future looks bright.

  2006cites this paper
• Incorporation of embryonic CA3 cell grafts into the adult hippocampus at 4-months after injury: effects of combined neurotrophic supplementation and caspase inhibition.

  2006cites this paper
• Important Aspects of Surgical Methodology for Transplantation in Parkinson's Disease

  2006cites this paper
• Neuroprotection with methylaminochroman and lazaroid of embryonic ventral mesencephalic tegmental dopaminergic neurons in cold storage.

  2006cites this paper
• Nerve growth factor increases survival of dopaminergic graft, rescue nigral dopaminergic neurons and restores functional deficits in rat model of Parkinson's disease.

  2006cites this paper
• Increased fiber outgrowth from xeno-transplanted human embryonic dopaminergic neurons with co-implants of polymer-encapsulated genetically modified cells releasing glial cell line-derived neurotrophic factor.

  2005cites this paper
• Caspase inhibition decreases cell death in regions of adult neurogenesis

  2005cites this paper
• β1 Integrin as a Xenoantigen in Fetal Porcine Mesencephalic Cells Transplanted into the Rat Brain

  2005cites this paper
• Caspase-mediated cell death predominates following engraftment of neural progenitor cells into traumatically injured rat brain.

  2005cites this paper
• New Therapeutic Approaches to Parkinson’s Disease Including Neural Transplants

  2005cites this paper
• Beta1 integrin as a xenoantigen in fetal porcine mesencephalic cells transplanted into the rat brain.

  2005cites this paper
• Combining Neuroprotective Treatment of Embryonic Nigral Donor Tissue with Mild Hypothermia of the Graft Recipient

  2005cites this paper
• Creatine Supplementation Improves Dopaminergic Cell Survival and Protects against MPP+ Toxicity in an Organotypic Tissue Culture System

  2005cites this paper
• Caspases; Modulators of Apoptosis and Cytokine Maturation — Targets for Novel Therapies

  2005cites this paper
• Evidence for dopaminergic re-innervation by embryonic allografts in an optimized rat model of the Parkinsonian variant of multiple system atrophy.

  2005cites this paper
• Neural stem cell differentiation is dependent upon endogenous caspase‐3 activity

  2005cites this paper
• Reassessment of Caspase Inhibition to Augment Grafted Dopamine Neuron Survival

  2004cites this paper
• Improving the survival of human CNS precursor‐derived neurons after transplantation

  2004cites this paper
• The cellular repair of the brain in Parkinson's disease--past, present and future.

  2004cites this paper
• A Review and Rationale for the Use of Cellular Transplantation as a Therapeutic Strategy for Traumatic Brain Injury

  2004influential citation
• Restorative potential of dopaminergic grafts in presence of antioxidants in rat model of Parkinson's disease.

  2004cites this paper
• Clinical potential of minocycline for neurodegenerative disorders.

  2004cites this paper
• Article Commentary: A Perspective on Transplantation Therapy and Stem Cells for Parkinson's Disease1

  2004cites this paper
• Pleiotrophin exhibits a trophic effect on survival of dopaminergic neurons in vitro

  2003cites this paper
• Both apoptosis and necrosis occur early after intracerebral grafting of ventral mesencephalic tissue : a role for protease activation

  2003influential citation
• Improvement of embryonic dopaminergic neurone survival in culture and after grafting into the striatum of hemiparkinsonian rats by CEP‐1347

  2003cites this paper
• Overexpression of heat shock protein 70 in R6/2 Huntington's disease mice has only modest effects on disease progression.

  2003cites this paper
• Neural Stem Cell Therapy in the Aging Brain: Pitfalls and Possibilities

  2003influential citation
• Strategies for the augmentation of grafted dopamine neuron survival.

  2003cites this paper
• Improved Survival of Grafted Dopamine Neurons by Calcineurin Inhibitors

  2003cites this paper
• Both apoptosis and necrosis occur early after intracerebral grafting of ventral mesencephalic tissue: a role for protease activation

  2003influential citation
• Ultrastructural Characterization of Dissociated Embryonic Ventral Mesencephalic Tissue Treated with Neuroprotectants

  2003cites this paper
• Both apoptosis and necrosis occur early after intracerebral grafting of ventral mesencephalic tissue: a role for protease activation.

  2003influential citation
• Therapeutic strategies targeting caspase inhibition following spinal cord injury in rats.

  2002cites this paper
• Cellular replacement therapy for Parkinson's disease--where we are today?

  2002cites this paper
• Neural transplantation for treatment of Parkinson's disease.

  2002cites this paper
• Combined neurotrophic supplementation and caspase inhibition enhances survival of fetal hippocampal CA3 cell grafts in lesioned CA3 region of the aging hippocampus.

  2002cites this paper
• Caspase inhibition by Z-VAD increases the survival of grafted bone marrow cells and improves functional outcome after MCAo in rats.

  2002cites this paper
• Book Review: Cellular Replacement Therapy for Parkinson’s Disease—Where We Are Today?

  2002cites this paper
• Effects of Antioxidant Pretreatment on the Survival of Embryonic Dopaminergic Neurons In Vitro and following Grafting in an Animal Model of Parkinson's Disease

  2002cites this paper
• Tauroursodeoxycholic Acid Improves the Survival and Function of Nigral Transplants in a Rat Model of Parkinson's Disease

  2002cites this paper
• Stem cells for neurodegenerative disorders: where can we go from here?

  2002cites this paper
• Comparison between survival of lazaroid-treated embryonic nigral neurons in cell suspensions, cultures and transplants.

  2002cites this paper
• Caspase inhibition: a potential therapeutic strategy in neurological diseases.

  2001cites this paper
• Partial resistance to malonate‐induced striatal cell death in transgenic mouse models of Huntington's disease is dependent on age and CAG repeat length

  2001cites this paper
• Neuroprotection of grafted neurons with a GDNF/caspase inhibitor cocktail.

  2001cites this paper
• The neurobiology of cell transplantation in Parkinson's disease

  2001cites this paper
• Resistance to NMDA toxicity correlates with appearance of nuclear inclusions, behavioural deficits and changes in calcium homeostasis in mice transgenic for exon 1 of the huntington gene

  2001cites this paper
• Evidence for target‐specific outgrowth from subpopulations of grafted human dopamine neurons

  2001cites this paper
• Death of dopaminergic neurons in vitro and in nigral grafts: reevaluating the role of caspase activation.

  2001cites this paper
• Bilateral caudate and putamen grafts of embryonic mesencephalic tissue treated with lazaroids in Parkinson's disease.

  2000influential citation
• Improving the survival of grafted embryonic dopamine neurons in rodent models of Parkinson's disease.

  2000cites this paper
• FK506 and cyclosporin A enhance the survival of cultured and grafted rat embryonic dopamine neurons.

  2000cites this paper
• P O B O X 1 1 7 2 2 1 0 0 L U N D + 4 6 4 6 -2 2 2 0 0 0 0

  year unknowncites this paper